Cannabinoid type 1 receptor (CB1R) is only stably surface expressed in axons, where it 2 downregulates neurotransmitter release. How this tightly regulated axonal surface polarity is 3 established and maintained is unclear. To address this question, we used time-resolved imaging to 4 determine the trafficking of CB1R from biosynthesis to mature polarised localisation. We show that 5 the secretory pathway delivery of CB1R is axonally biased and that surface expressed CB1R is more 6 stable in axons than in dendrites. This dual mechanism is mediated by the CB1R C-terminal and 7 involves the Helix 9 (H9) domain. Removal of the H9 domain increases dendrite secretory pathway 8 delivery and decreases in surface stability. Furthermore, CB1R ΔH9 is more sensitive to agonist-9 induced internalisation and less efficient at downstream signalling than CB1R WT . Together, these 10 results shed new light on how polarity of CB1R is mediated and indicate that the C-terminal H9 11 domain plays key roles in this process. 12 13 Keywords 14 cannabinoid receptor type 1; CB1R; trafficking; surface expression; polarity; axonal; endocytosis; 15 RUSH 16 17 1 Ahn, K. H., Nishiyama, A., Mierke, D. F. and Kendall, D. A. (2010). Hydrophobic residues in helix 8 of 2 cannabinoid receptor 1 are critical for structural and functional properties. Biochemistry 49, 502-11. . (2009). 4
Introduction 18 CB1R is one of the most abundant G-protein-coupled receptors (GPCRs) in the CNS and 19 endocannabinoid signalling through CB1R is a neuromodulatory system that influences a wide range 20 of brain functions including pain, appetite, mood, and memory (Lu and Mackie, 2016; Soltesz et al., How this near exclusive axonal surface expression of CB1R is established remains the subject of 32 debate. One suggestion is that high rates of endocytosis due to constitutive activity selectively 33 remove CB1Rs from the somatodendritic compartment, resulting in an accumulation at the axonal 34 surface (Leterrier et al., 2006) . These internalised somatodendritic CB1Rs may then be either sorted 35 for degradation or recycled to axons via a transcytotic sorting pathway (Simon et al., 2013) . 36
Alternatively, newly synthesized CB1R may be constitutively targeted to lysosomes, but under 37 appropriate circumstances the CB1Rs destined for degradation are retrieved and rerouted to axons 38 (Rozenfeld, 2011; Rozenfeld and Devi, 2008) . 39 Surprisingly, a direct role for the 73-residue intracellular C-terminal domain of CB1R (ctCB1R) in 40 axonal/somatodendritic trafficking or polarised surface expression has not been identified. It has, 41 however, been reported that motifs within ctCB1R are required for receptor desensitization and Here we systematically investigated how axonal surface polarity of CB1R arises by tracking newly-49 synthesised CB1Rs through the secretory pathway to their surface destination. We demonstrate that 50 a population of CB1R is preferentially targeted to the axon through the biosynthetic pathway. CB1Rs 51 that reach the dendritic membrane are rapidly removed by endocytosis whereas CB1Rs surface 52 expressed on the axonal membrane have a longer residence time. We further show that the putative 53 helical domain H9 in ctCB1R plays a key role in CB1R surface expression and endocytosis in 54 hippocampal neurons. Taken together our data suggest that CB1R polarity is determined, at least in 55 part, by a novel determinant in the C-terminus of CB1R that contributes to targeted delivery to the 56 axonal compartment and the rapid removal of CB1Rs that reach the somatodendritic membrane. 57
Results 58 Preferential delivery of newly synthesized CB1Rs to, and retention at, the axonal membrane 59 establishes surface polarisation. 60
To investigate how CB1R surface polarity is established we used the retention using selective hooks 61 (RUSH) system (Boncompain et al., 2012) to examine its secretory pathway trafficking. CB1R was 62 tagged at the N-terminus with streptavidin binding peptide (SBP) and EGFP (SBP-EGFP-CB1R). 63
When co-expressed with a Streptavidin-KDEL 'hook' that localises to the lumen of the Endoplasmic 64 Reticulum (ER), SBP-EGFP-CB1R is anchored at the ER membrane. The retained SBP-EGFP-65 CB1R can then be synchronously released by addition of biotin and its trafficking through the 66 secretory pathway and surface expression in both axons and dendrites can be monitored (Evans et  67 al., 2017). 68 CB1R is directly trafficked to the axon through the secretory pathway. 69
We first examined the synchronous trafficking of total SBP-EGFP-CB1R in the somatodendritic and 70 axonal compartments of primary hippocampal neurons ( Fig. 1A-C) . Prior to biotin-mediated release, 71 SBP-EGFP-CB1R was retained in the ER in the soma and dendrites but was absent from the axonal 72 compartment and was not present at the cell surface (0 min; Fig. 1A ). After addition of biotin, SBP-73 EGFP-CB1R moved through the secretory pathway and entered the axonal compartment at 25 min 74 and continued to accumulate until 45 min when it reached its peak, which was comparable to an 75 unretained control (O/N) ( Fig. 1B-C) . These data suggest that once released from the ER, CB1R is 76 immediately trafficked towards the axonal compartment via the intracellular secretory pathway. 77
De novo CB1R is more rapidly surface expressed in axons than in dendrites. 78
Having established that SBP-EGFP-CB1R released from the ER traffics directly to axons, we next 79 investigated where and when the newly synthesised SBP-EGFP-CB1R first reaches the plasma 80 membrane. We determined how much SBP-EGFP-CB1R was surface expressed during a given time 81 period using an antibody feeding assay (Evans et al., 2017). Antibody feeding was performed 82 concurrent with the addition of biotin to release ER-retained SBP-EGFP-CB1R. This protocol labels 83 both surface expressed CB1Rs and those that have been surface expressed and subsequently 84 endocytosed ( Fig. 1D-G; surface+endocytosed), giving a measure of total amount of surface 85 expression irrespective of internalisation. SBP-EGFP-CB1R was surface expressed in axons 40 min 86 after release from the ER, whereas in dendrites, CB1R was not surface expressed until 60 min after 87 release ( Fig. 1E) . Moreover, significantly more SBP-EGFP-CB1R reached the surface of axons than 88 the surface of dendrites 45, 60 and 90 min after release from the ER (Fig. 1E) . These data 89 demonstrate that the secretory pathway delivers a greater amount of CB1R more rapidly to the 90 axonal membrane than to the dendritic membrane. 91
De novo CB1R is retained longer at the surface of axons than of dendrites. 92
It has been suggested CB1R polarity is maintained by differential rates of endocytosis in the 93 somatodendritic and axonal compartments (Leterrier et al., 2006; McDonald et al., 2007a) . To test 94 this, we also stained for surface SBP-EGFP-CB1R and compared the amount of surface expressed 95 SBP-EGFP-CB1R to the amount of surface+endocytosed SBP-EGFP-CB1R in axons ( Fig. 1D,F ) 96 and dendrites ( Fig. 1D,G) . In axons the normalised surface and surface+endocytosed curves were 97 identical, suggesting that most surface expressed SBP-EGFP-CB1R is stable and retained at the 98 membrane ( Fig. 1D,F) . This may be due either to minimal endocytosis or to the efficient recycling of 99 endocytosed receptors. In stark contrast, however, in dendrites there is significantly less surface 100 than surface+endocytosed SBP-EGFP-CB1R 90 min after addition of biotin, indicating that surface 101 expressed CB1R is more rapidly endocytosed from and/or not recycled back to the dendritic 102 membrane ( Fig. 1G) . 103
Our results using RUSH time-resolved analysis show that CB1R surface polarity is established and 104 maintained by two distinct but complementary mechanisms. Firstly, we show the novel finding that 105 the secretory pathway preferentially delivers CB1R to the axonal surface, with significantly less going 106 to the dendritic surface. Secondly, by distinguishing between surface and surface+endocytosed 107 receptors, our antibody feeding experiments show that newly delivered CB1R is preferentially 108 retained/stabilised at the axonal membrane and internalised from the dendritic membrane. Previous 109 literature proposes that this differential internalisation is due to the presence of agonist in the Furthermore, the function of the Helix 9 (H9) structural motif is unknown. We therefore wondered 119 whether ctCB1R, or H9 in particular, may contribute to CB1R surface polarisation. 120
To test this, we used CD4, a single-pass membrane protein that has no intrinsic localisation signals 121 and is normally surface expressed in a non-polarised manner (Fache et al., 2004; Garrido et al., 122 2001) . We expressed chimeras of CD4 alone, or CD4 fused to either ctCB1R WT or a ctCB1R lacking 123 the H9 domain (ctCB1R ΔH9 ; Fig. 2A ). In hippocampal neurons we examined each of the CD4 124 chimeras' surface expression by immunostaining. 125
Analysis of the axon to dendrite ratio of surface expression (the surface polarity index) revealed that 126 CD4-ctCB1R WT was markedly more axonally polarised than CD4 alone, indicating that ctCB1R may 127 play a role in polarisation despite its lack of defined canonical localisation signals ( Fig. 2B, 2C) . 128 Moreover, although still significantly axonally polarised, the degree of polarisation was significantly 129 lower for CD4-ctCB1R ΔH9 , suggesting that H9 may also contribute to this process. 130 H9 restricts delivery of CB1R to the dendritic membrane. 131
To further explore the possibility that H9 is involved in the axonal surface polarity of CB1R, we used 132 RUSH to compare the forward trafficking of SBP-EGFP-CB1R WT and SBP-EGFP-CB1R ΔH9 . As in 133 Fig. 1 , we labelled all the CB1R that had been surface expressed (surface+endocytosed) 0, 30, 60 134 and 90 min after biotin release from the ER (Fig. 3A-G) . 135
Interestingly, significantly more SBP-EGFP-CB1R ΔH9 than SBP-EGFP-CB1R WT reached the surface 136 of dendrites during time course of our experiments ( Fig. 3B) , whereas trafficking to axons was similar 137 for both SBP-EGFP-CB1R WT and SBP-EGFP-CB1R ΔH9 (Fig. 3C) . These altered properties resulted 138 in a significant difference in the surface+endocytosed polarity index after 90 min ( Fig. 3D ) and are 139 consistent with a role for H9 in restricting delivery of CB1R to the dendritic membrane. 140
H9 plays a role in the surface retention of CB1R. 141 Surprisingly, however, in contrast to the total amount of CB1R that had been surface expressed 142 during the time course (surface+endocytosed) (Fig. 3D ) the polarity of the amount of CB1R on the 143 cell surface 90 min after biotin-mediated release was identical for SBP-EGFP-CB1R WT and SBP-144 EGFP-CB1R ΔH9 (surface; Fig. 3E ). 145 Closer analysis revealed identical levels of axonal surface expression of both SBP-EGFP-CB1R WT 146 and SBP-EGFP-CB1R ΔH9 60 min after release from the ER. However, at 90 min there is significantly 147 less surface expression of ΔH9 mutant ( Fig. 3F) suggesting that, although similar amounts of SBP-148 EGFP-CB1R WT and SBP-EGFP-CB1R ΔH9 reach the surface, surface expression of SBP-EGFP-149 CB1R ΔH9 is less stable than that of the wild-type. 150 Furthermore, in dendrites, the increased delivery and surface trafficking of the ΔH9 mutant is 151 counteracted by the fact that less is retained at the surface 60 min after ER release ( Fig. 3G) . 152
Taken together these results suggest that, separate from its role in restricting delivery to the dendritic 153 membrane, H9 also plays a role in membrane stability and retention at both axons and dendrites.
H9 stabilises CB1R at the surface. 155
To investigate the role of H9 in membrane stability, we next compared surface expression ( Fig. 4A ) 156 and endocytosis ( Fig. 4B ) of EGFP-CB1R WT and EGFP-CB1R ΔH9 in axons and dendrites at steady-157 state. EGFP-CB1R ΔH9 displayed lower levels of surface expression ( Fig. 4C) , as well as increased 158 endocytosis ( Fig. 4D) in both axons and dendrites compared to EGFP-CB1R WT , suggesting H9 plays 159 a role in stabilising CB1R at the surface of both axons and dendrites. Moreover, similar to our findings 160 using RUSH, there was there was no difference in surface polarity between wild-type and EGFP-161 CB1R ΔH9 (Fig. 4E) . These findings suggest that, while H9 plays a role in CB1R surface expression 162 and endocytosis, its potential to mediate surface polarity is masked in the context of the full-length conditions in the absence of ACEA. However, upon ACEA stimulation, the level of ERK1/2 activation 174 was significantly reduced in EGFP-CB1R ΔH9 -transfected cells compared to EGFP-CB1R WT -175 transfected cells expressing equivalent amounts of receptor ( Fig. 5A-C ), suggesting the ΔH9 mutant 176 is deficient in its ability to activate downstream signalling pathways. 177
We next monitored ACEA-induced internalisation of EGFP-CB1R WT and EGFP-CB1R ΔH9 in axons of 178 hippocampal neurons ( Fig. 5D) . ACEA-induced internalisation of EGFP-CB1R ΔH9 was significantly 179 greater than that observed for EGFP-CB1R WT (Fig. 5E) . Taken together, these data indicate that 180 CB1R ΔH9 is less stable at the axonal surface under basal conditions and that it is more susceptible 181 to agonist-induced internalisation. 182
The role of H9 in polarity is revealed in the presence of inverse agonist. 183
Our data thus far have indicated that ctCB1R, and the H9 domain in particular, can mediate surface 184 polarity of a CD4 chimera (Fig. 2) , and promote polarised surface delivery of CB1R (Fig. 3) . In 185 contrast, deletion of H9 has no effect on CB1R surface polarity at steady-state ( Fig. 4) . However, 186 deletion of H9 does have a striking effect on the surface stability of CB1R -CB1R ΔH9 is less surface 187 expressed in both axons and dendrites and shows increased endocytosis ( Figs. 3 and 4) . 188
Furthermore, CB1R ΔH9 is more responsive to agonist-induced internalisation ( Fig. 5) . We therefore 189 wondered whether the difference between the CD4 chimeras and the full-length receptor, and the 190 difference between surface+endocytosed and surface polarity, may be due to the agonist binding 191 capability of the full-length receptor. Inverse agonist treatment, which prevents the receptor entering 192 an active conformation, has previously been shown to increase somatodendritic surface expression 193 similarly to treatment with an endocytosis inhibitor (Leterrier et al., 2006) . We thus reasoned that in 194 this case, inverse agonist treatment may reveal a difference in surface polarity between EGFP-195 CB1R WT and EGFP-CB1R ΔH9 , like that observed with the CD4 chimeras and in surface+endocytosed 196
polarity. 197
We treated hippocampal neurons expressing either EGFP-CB1R WT or EGFP-CB1R ΔH9 with the 198 CB1R-specific inverse agonist AM281 (Leterrier et al., 2004) ( Fig. 6A) . In the DMSO control both 199 EGFP-CB1R WT and EGFP-CB1R ΔH9 displayed similar levels of surface polarity. In the presence of 200 AM281, however, EGFP-CB1R ΔH9 had significantly reduced surface polarity compared EGFP-201 CB1R WT (Fig. 6B ) due to a significantly increased amount of dendritic surface expression ( Fig. 6C) . 202
These data suggest that in the absence of constitutive activity of the receptor, H9 plays a role in 203 mediating CB1R surface polarity. Furthermore, these data suggest that the increased internalisation 204 observed in dendrites with H9 deletion may be mediated by the presence of agonist. Finally, our 205 findings reaffirm the importance the state-dependent effect on CB1R trafficking. 206
Discussion 207
Our data indicate that axonal surface polarity of CB1R occurs as a result of two distinct, but 208 complementary, mechanisms. 1) Using time-resolved RUSH assays we demonstrate that more de 209 novo CB1R is delivered to the axon and that it is more rapidly surface expressed than in dendrites. 210
2) Once at the axonal membrane the newly delivered CB1R is more stably retained whereas in 211 dendritic membrane CB1R surface expression is transient and it is rapidly internalised. However, we 212 also note that our data do not specifically exclude the possibility that CB1R internalised into the 213 somatodendritic endocytosed compartment can be rerouted to the axon via the transcytosis 214 pathway, thus further facilitating axonal polarity (Simon et al., 2013). 215
Furthermore, since CD4-ctCB1R WT and CD4-ctCB1R ΔH9 chimeras cannot bind agonist, our results 216 are consistent with ctCB1R contributing to constitutive polarisation via a mechanism distinct from the 217 proposed continuous activation of CB1R by the presence of the endogenous agonist 2-218 Arachidonoylglycerol (2-AG) in the dendritic membrane (Ladarre et al., 2014). Our data suggest that 219 ctCB1R, especially H9, plays a role in constitutive preferential delivery of CB1R to the axonal 220 membrane. 221
Our results further demonstrate that ctCB1R is important for maintaining axonal surface polarity, in 222 part mediated by the H9 motif, which plays a role in both the preferential delivery and selective 223 retention of CB1R at in axons. We show that deleting H9 (CB1R ΔH9 ) has a range of effects on 224 trafficking, surface expression and signalling in hippocampal neurons. More specifically, these 225 include; i) CB1R ΔH9 lacks the preferential delivery to axons observed for CB1R WT , ii) CB1R ΔH9 is less 226 efficiently surface expressed, iii) CB1R ΔH9 that does reach the surface it is more rapidly endocytosed 227 in both axons and dendrites and iv) CB1R ΔH9 is more sensitive to agonist-induced internalisation and 228 less efficient at downstream signalling, monitored by activation of ERK1/2 phosphorylation. 229
Preferential axonal trafficking. 230
The mechanism behind polarised membrane trafficking in neurons is a fundamental question and 231 our data suggest a sorting mechanism at the level of the secretory pathway that preferentially targets CB1R to the axon. Since dendritic and axonal cargo are synthesized in the somatodendritic 233 compartment, selective sorting to the correct domain is crucial. While several sorting signals and 234 adaptors have been described for dendritic cargo, the mechanisms behind selective sorting to axons 235 are less well known (Lasiecka and Winckler, 2011, Bentley, 2016 #43663). For example, a recent 236 study in C. elegans has suggested that sorting of cargos to axons or dendrites depends on binding 237 to different types of clathrin-associated adaptor proteins (AP); axonal cargo bind to AP-3 whereas 238 dendritic cargo bind to AP-1 (Li et al., 2016). Interestingly, AP-3 binding has been associated with 239 CB1R trafficking to the lysosome in the dendritic compartment (Rozenfeld and Devi, 2008). One 240 possibility is that H9 may modulate CB1R binding to AP-3, reducing both preferential delivery to 241 axons and, perhaps, reducing sorting to lysosomes, causing an increase in dendritic membrane 242 CB1R. More studies are needed to examine the possibility of H9 influencing AP-3 and CB1R 243 interaction. 244 H9 and membrane retention. 245
Our data suggest that H9 stabilises CB1R at the membrane, regardless of compartment. While the 246 H8 domain is highly conserved in GPCRs, structural domains analogous to H9 have only been 247 Therefore, it is possible that H9 mediates the interactions between CB1R and SGIP1 and/or 260 selectively promotes β-Arrestin rather than CRIP1a binding. Further studies examining the 261 interaction between CB1R WT , CB1R ΔH9 , CRIP1a, β-Arrestin1/2, and SGIP1 are needed to examine 262 the mechanism by which H9 stabilises surface CB1R. Chicken anti-GFP was from Abcam (ab13970); mouse anti-Ankyrin-G was from NeuroMab (clone 280 N106/36); rabbit anti-MAP2 was from Synaptic Systems (188 003); mouse anti-CD4 was from 281
BioLegend (clone OKT4); rat anti-GFP was from ChromoTek (3H9); anti-phosphoERK (M7802), and 282 anti-non-phosphoERK (M3807) were from Sigma; mouse anti-GAPDH (6C5 ab8245) was from 283
Abcam. All fluorescent secondaries were from Jackson Immunoresearch Laboratories and HRP 284 conjugated secondaries were from Sigma. ACEA and AM281 were from Tocris bio-techne. To measure surface staining, cultured neurons were cooled at room temperature for 5-10 min, then 308 incubated with the appropriate antibody (chicken anti-GFP or mouse anti-CD4) in conditioned media 309 for 10-20 min at RT. The neurons were washed multiple times in PBS before fixation. 310
For agonist and inverse agonist experiments, the neurons were treated with 5μM ACEA (in EtOH) 311 or vehicle control (0.1% EtOH) for 3 hours or 10μM AM281 (in DMSO) or vehicle control (0.2% 312 DMSO) for 3 hours in conditioned media at 37°C and 5% CO2, and then subsequently surface 313 stained. 314
To measure endocytosed receptors, neurons were fed with chicken anti-GFP for 2h in conditioned 315 media at 37°C and 5% CO2. Neurons were washed several times in PBS and then surface antibody 316 was stripped by 2 quick washes with ice-cold pH 2.5 PBS followed by several washes in PBS before 317 fixation. 318
RUSH live labelling. 319
Neurons were transfected with RUSH constructs at DIV 12 for no longer than 24 hours to prevent 320 ER stress resulting from accumulation of unreleased receptors. Neurons were incubated in 321 conditioned media containing D-biotin (40μM, Sigma) and chicken anti-GFP (1:1,000) for different 322 lengths of time at 37°C and 5% CO2. The 0 min timepoint was only incubated with chicken anti-GFP 323 without biotin for 60 min. For the O/N timepoint, neurons were incubated in 40μM D-biotin 324 immediately following transfection and then left overnight at 37°C and 5% CO2 before being 325 incubated with biotin and chicken anti-GFP for 60 min to label surface CB1R. Every independent 326 experiment included a 60 min timepoint to which values were normalised and a 0 min control. 327
Following biotin treatment, neurons were washed several times in PBS and cooled to 4°C to prevent 328 further internalisation. They were then live labelled with 647-labelled anti-chicken in conditioned 329 media for 15 min at 4°C before being fixed and permeabilised and stained with Cy3-labelled anti-330 chicken. In the text, "surface" thus refers to 647 fluorescence acquisition, whereas 331 "surface+endocytosed" refers to Cy3 fluorescence acquisition. 332
Fixation and fixed immunostaining. 333
Cultured neurons were fixed in 4% formaldehyde in PBS for 12 min, then washed 3x in PBS, 1x in 334 100mM Glycine in PBS, and 3x in PBS. The neurons were then blocked and permeabilised in PBS 335 3% BSA. Subsequently, the neurons were re-incubated in primary antibody (anti-GFP or anti-CD4) 337 to measure total levels of expression and stained with either anti-MAP2 (dendritic marker) or anti-338
Ankyrin-G (axonal initial segment marker) in PBS + 3% BSA. The neurons were then washed several 339 times in PBS and mounted onto glass slides using Fluoromount-G (ThermoFisher Scientific). 340
Image acquisition and analysis. 341
Images were acquired using either a Leica SPE single channel confocal laser scanning microscope 342 or a Leica SP8 AOBS confocal laser scanning microscope (Wolfson Bioimaging Facility, University 343 of Bristol). All settings were kept the same within experiments. Neurons used for data acquisition 344 were selected only on their total staining. 345
All quantification was performed using ImageJ software. Based on previous experiments, at least 346 five cells were analysed per experiment, and at least three independent experiments (i.e. on different 347 neuronal cultures on different days) were performed. 348
Images were max projected, and regions of interest (ROIs) of approximately similar lengths were 349 drawn around axons and 3-4 proximal and secondary dendrites based on the total channel only. 350
Axons were defined either as processes whose initial segment was positive for Ankyrin-G or as 351 processes negative for MAP2. The mean fluorescence was measured for each channel and the 352 dendritic values were averaged. "Surface" or "endocytosed" mean fluorescence values were 353 normalised to the "total" mean fluorescence value for each ROI to account for varying levels of 354 expression of transfected constructs. These values were then normalised to the axon value of the 355 control (WT, WT + vehicle, or CD4). 356
Because of the change in total mean fluorescence in axons throughout the different conditions, the 357 above image analysis was slightly modified for RUSH experiments. In these experiments, neurites 358 were traced using NeuronJ so that only the mean fluorescence of exactly the first 50μm of the axons 359 and 30-40μm of 2-4 primary dendrites for each channel was measured. All "surface" and 360 "surface+endocytosed" values (of both axons and dendrites) were normalised to the average total 361 dendritic value for each neuron. Axon total mean fluorescence was also normalised to the average total dendritic value within each cell. All values were then normalised to the WT 60 min axon value 363 within each experiment. 364 "Polarity indices (A/D ratio)" were calculated by dividing the axonal mean fluorescence value by the 365 average dendritic mean fluorescence value. 366
The scalebar for all images represents 20μm. 367
Statistics. 368
All statistics were performed using GraphPad Prism. The ROUT method was used to identify outliers 369 for all parameters measured before normalising to control. Neurons were removed from analysis if 370 any one parameter was found to be an outlier. To determine statistical significance between two 371 groups, a D'Agostino & Pearson normality test was performed. Unpaired t-tests were performed on 372 data that passed the normality test whereas the Mann-Whitney test was used if it did not. One-or 373 Two-way ANOVAs with Tukey's or Sidak's post hoc test were used to determine statistical 374 significance between more than two groups depending on the comparisons required. . J., Coutts, A. A., Harvey, J., Rae, M. G., Mackie, K., Bewick, G. S. and Pertwee, R. G. (2000) . 51
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